Best Life Sciences Tech Companies in Berlin, Germany
The 47 best Life Sciences Tech companies in Berlin, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ResearchGate.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Berlin
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ResearchGate Online community for scientists | $88M | 67 mo ago | Series D | Horst Fickenscher CIO & Co-Founder | 2008 | GitBookZendeskApple iCloud Mail+14 | — | 1 partnership |
| 2 | Aignostics Developer of artificial intelligence software for biomedical image analysis applications 64AI top 25%Growth top 26%Funding top 27%Talent top 28% All 11 signals ▾AItop 25% Growthtop 26% Fundingtop 27% Talenttop 28% Moattop 39% Innovationtop 47% Patentstop 47% Techbottom 49% Globalbottom 37% Marketbottom 35% Newsbottom 18% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Growth: Headcount 10 → 25 (+150%) across vintages · Web rank 5,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 64/100 | $55M | 21 mo ago | Series B | Maximilian Alber Co-Founder & CTO | 2018 | WebflowApple iCloud MailGoogle Workspace+18 | 5 patents AI-powered detection and classification of biological structures for medical imaging diagnostics. | 1 partnership · 1 award |
| 3 | StratifAI Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment 55Talent top 28%AI top 30%Funding top 32%Tech top 42% All 7 signals ▾Talenttop 28% AItop 30% Fundingtop 32% Techtop 42% Growthtop 45% Globalbottom 39% Marketbottom 29% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 55/100 | $16M | 10 mo ago | Series A | Firas Khader CTO & Co-founder | 2023 | WordPressApple iCloud MailMicrosoft 365+25 | — | — |
| 4 | Molecule Platform where drug development researchers and investors collaborate to invent therapeutics | $13M | 49 mo ago | Seed | Paul Kohlhaas Co-Founder & CEO | 2018 | SanityTurbopackstyled-components+17 | — | 1 launch |
| 5 | Apheris Provider of data analytics solutions for life science industry 53AI top 20%Growth top 35%Talent top 38%Funding top 39% All 10 signals ▾AItop 20% Growthtop 35% Talenttop 38% Fundingtop 39% Partnerstop 41% Techbottom 43% Globalbottom 39% Moatbottom 38% Marketbottom 30% Newsbottom 18% AI: Classified as an AI company Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $12M | 19 mo ago | Series A | Robin Rohm Co-Founder & CEO & MD | 2019 | DatoCMSNode.jsUnoCSS+10 | — | — |
| 6 | Labforward Laboratory data, devices, and researchers collaboration platform | $10M | 63 mo ago | Acquired | — | 2013 | HubSpot CMS HubReactEmotion+27 | — | — |
| 7 | Nostos Genomics Developer of AI platform for interpretation of genetic variants and mutations | $6M | 54 mo ago | Seed | — | 2018 | — | 3 patents AI-driven computational classification and prioritization of genetic variants in genomics | — |
| 8 | Healthmetrix Digital solutions to aggregate and analyze data from multiple sources for research purposes | $2M | 91 mo ago | Funding Raised | Gabriel Sieglerschmidt Founder & CEO | 2018 | — | — | — |
| 9 | Exazyme Developer of an AI protein design tool for biotech innovators | $2M | 39 mo ago | Seed | Jelena Ivanovska Co-Founder | 2021 | — | — | — |
| 10 | Yendou Provider of a site engagement platform for clinical trials | $1M | 29 mo ago | Seed | Zina Sarif Founder & CEO | 2022 | GSAPLiteSpeedCloudflare+11 | — | — |
| 11 | Yendou Provider of data management and CRM platform for clinical operations | $1M | 29 mo ago | Seed | Patrick Rogg Co-Founder | 2022 | — | — | — |
| 12 | BioNeex Provider of SaaS-based drug licensing and drug candidate partnership exchange platform for the biopharma… | $500K | 29 mo ago | Seed | Smbat Rafayelyan Founder & CEO | 2018 | — | — | 1 launch · 1 partnership |
Top 12 Life Sciences Tech companies in Berlin
#1
Series A · Berlin, Berlin · founded 2023$16.3Mraised▾
Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment. The company's proprietary algorithms analyze the image, assessing various patterns that indicate the recurrence risk of breast cancer to provide a comprehensive prognostic evaluation.
- Sep 2025Series A$14.7M
- Sep 2024Seed$1.7M
#2
Series B · Berlin, Berlin · founded 2018 · 25 employees$55Mraised▾
Developer of artificial intelligence software for biomedical image analysis applications. This technology processes pathology samples to identify drug targets and biomarkers. The software utilizes foundation models to generate embeddings for downstream analysis of tumor microenvironments. These tools support research in drug development and clinical diagnostics by predicting expression patterns and classifying cell types within tissue images.
- Oct 2024Series B$34M
- Sep 2022Series A$14M
- Aug 2020Seed$5.9M
#3
Series A · Berlin, Berlin · founded 2019 · 19 employees$12.2Mraised▾
Provider of data analytics solutions for life science industry. The platform enables organizations to collaborate on distributed data in real time. It offers a federated computational governance solution to support data-driven analysis. The platform allows users to build federated data networks to enable hospitals, fellow researchers and other pharmaceutical innovators to build predictive models.
- Jan 2025Series A$20.8M
- Nov 2022Seed$8.7M
- Aug 2020Seed$3M
- Grant (prize money)—
#4
Series D · Berlin, Berlin · founded 2008 · 150 employees$87.6Mraised▾
ResearchGate is an online community for scientists and researchers to share papers, ask and answer questions, and find collaborators. It has a blogging feature for users to write short reviews on peer-reviewed articles. It also has private chat rooms where scientists can share data, edit shared documents, and discuss confidential topics. The application is available for iOS devices.
- Dec 2020Grant (prize money)$18.5K
- Feb 2017Series D$52.6M
- May 2013Series C$35M
- Feb 2012Series B—
#5
Seed · Berlin, Berlin · founded 2018 · 31 employees$12.7Mraised▾
Platform where drug development researchers and investors collaborate to invent therapeutics. It offers a web3 marketplace for biotech DAOs that connects academics and biotech companies for research-related IP.
- Jun 2022Seed$12.7M
#6
Seed · Berlin, Berlin · founded 2022$1.3Mraised▾
Provider of a site engagement platform for clinical trials. This platform streamlines the process of clinical trial site identification, activation, and engagement. It consolidates site data, automates communication, and improves knowledge retention across teams. The platform facilitates efficient collaboration between sponsors, CROs, and research sites without requiring sites to use additional technology. This results in faster study timelines and reduced administrative burden for all parties involved. The platform's features include a global site directory, a knowledge retention engine, and tools for scalable, personalized engagement.
- Feb 2024Seed$1.3M
#7
Seed · Berlin, Berlin · founded 2022 · 3 employees$1.3Mraised▾
Developer of medical research platform designed to accelerate clinical drug development and make clinical research accessible to principal investigators and patients. The company's platform allows researchers and organizations to manage the feasibility and site selection of multinational studies in a shorter span of time by connecting healthcare professionals with healthcare providers and providing principal investigators to search, select and apply to clinical trials of interest from a pool of pre-selected studies sponsored by world-class companies.
#8
Seed · Berlin, Berlin · founded 2021 · 5 employees$2.2Mraised▾
Developer of an AI protein design tool for biotech innovators. The tool handles targets for multiple properties and secures data and intellectual property. It offers an application to predict protein evolutions more efficiently using an AI-based algorithm. The application distills data patterns into actionable findings, providing quality candidates. Users upload data, configure jobs, and download results for wet lab testing to evolve proteins.
- May 2023Seed$2.2M
- 2022Grant (prize money)—
#9
Acquired · Berlin, Berlin · founded 2013 · 45 employees$10.2Mraised▾
Labforward offers laboratory data, devices, and researchers collaboration platforms. Its offerings Labfolder is an electronic lab notebook (ELN) that can optimize the daily life of a scientist by simplifying correct data documentation. The platform combines the most important features present in ELNs and a Laboratory Information Management Systems (LIMS), and Laboperator is the plug & play solution to connect all the lab instruments in a single platform.
- May 2021Series B—
- Jan 2021Series B$4.9M
- Feb 2020Series A—
- 2015Seed—
#10
Seed · Berlin, Berlin · founded 2018 · 13 employees$500Kraised▾
Provider of SaaS-based drug licensing and drug candidate partnership exchange platform for the biopharma industry. The company has developed an R&D exchange platform that has features for searching drug candidates, drug pipelines, and market trend insights.
- Feb 2024Seed$500K
#11
Seed · Berlin, Berlin · founded 2018 · 20 employees$5.6Mraised▾
Developer of AI platform for interpretation of genetic variants and mutations. The platform helps identify likely pathogenic variants. It enables genetic testing labs to provide diagnoses. The AI-driven system automatically interprets variants. It provides decision support that improves classification.
- Feb 2022Seed$5.6M
- Mar 2019Seed—
#12
Funding Raised · Berlin, Berlin · founded 2018$2.3Mraised▾
Digital solutions to aggregate and analyze data from multiple sources for research purposes. The company provides a platform for that enables the transfer of treatment data to researchers, remove personal information from health data, converts data in different formats, and digitally obtain consent from study participants.
- Jan 2019Grant (prize money)$2.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Berlin is moving
A read on the academic research around Biotechnology in Berlin — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 91 papers.
- Freie Universität Berlin31
- Charité - Universitätsmedizin Berlin31
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin17
- Humboldt-Universität zu Berlin15
- Technische Universität Berlin12
- Immune system3
- T cell3
- Cytotoxic T cell3
- Gene3
- T-cell receptor2
- Microglia3
- Downregulation and upregulation3
- DNA methylation2
- Gene2
- Mast cell2
- Antibiotic resistance3
- Production (economics)3
- Antimicrobial2
- Food processing2
- Product (mathematics)2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.